181 related articles for article (PubMed ID: 36553620)
21. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 genetic polymorphisms of Mexican indigenous populations.
Sosa-Macías M; Llerena A
Drug Metabol Drug Interact; 2013; 28(4):193-208. PubMed ID: 24145057
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
Muñoz S; Vollrath V; Vallejos MP; Miquel JF; Covarrubias C; Raddatz A; Chianale J
Pharmacogenetics; 1998 Aug; 8(4):343-51. PubMed ID: 9731721
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs.
Stingl J; Viviani R
J Intern Med; 2015 Feb; 277(2):167-177. PubMed ID: 25297512
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.
Dandara C; Masimirembwa CM; Magimba A; Sayi J; Kaaya S; Sommers DK; Snyman JR; Hasler JA
Eur J Clin Pharmacol; 2001 Apr; 57(1):11-7. PubMed ID: 11372584
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 humanised mice.
Gonzalez FJ
Hum Genomics; 2004 May; 1(4):300-6. PubMed ID: 15588489
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups.
Britzi M; Bialer M; Arcavi L; Shachbari A; Kapitulnik T; Soback S
Ther Drug Monit; 2000 Oct; 22(5):510-6. PubMed ID: 11034254
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility.
Smith CA; Moss JE; Gough AC; Spurr NK; Wolf CR
Environ Health Perspect; 1992 Nov; 98():107-12. PubMed ID: 1486838
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
Dahl ML
Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
[TBL] [Abstract][Full Text] [Related]
32. In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans.
Yaïch M; Popon M; Médard Y; Aigrain EJ
Pharmacogenetics; 1998 Oct; 8(5):449-51. PubMed ID: 9825837
[TBL] [Abstract][Full Text] [Related]
33. Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis.
Sen A; Stark H
World J Gastroenterol; 2019 Jun; 25(23):2846-2862. PubMed ID: 31249444
[TBL] [Abstract][Full Text] [Related]
34. [Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese].
Yokoi T; Kamataki T
Nihon Yakurigaku Zasshi; 1998 Jul; 112(1):5-14. PubMed ID: 9755457
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6.
Kitada M
Int J Clin Pharmacol Res; 2003; 23(1):31-5. PubMed ID: 14621071
[TBL] [Abstract][Full Text] [Related]
36. Identification of the human cytochromes P450 responsible for atomoxetine metabolism.
Ring BJ; Gillespie JS; Eckstein JA; Wrighton SA
Drug Metab Dispos; 2002 Mar; 30(3):319-23. PubMed ID: 11854152
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of cytochrome P450 and methods for its determination.
Buzková H; Pechandová K; Slanar O; Perlík F
Prague Med Rep; 2006; 107(4):383-93. PubMed ID: 17402551
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN).
Atanasova SY; von Ahsen N; Toncheva DI; Dimitrov TG; Oellerich M; Armstrong VW
Clin Biochem; 2005 Mar; 38(3):223-8. PubMed ID: 15708542
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of cytochromes P450.
Hasler JA
Mol Aspects Med; 1999; 20(1-2):12-24, 25-137. PubMed ID: 10575648
[No Abstract] [Full Text] [Related]
40. Molecular genetics of the human cytochrome P450 monooxygenase superfamily.
Smith G; Stubbins MJ; Harries LW; Wolf CR
Xenobiotica; 1998 Dec; 28(12):1129-65. PubMed ID: 9890157
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
